Monthly Prescribing Reference

New Tablet Formulation of Livmarli Gets FDA Approval

When selecting the appropriate formulation of Livmarli, the patient's weight and ability to swallow tablets should be considered. Livmarli tablets are supplied in 10mg, 15mg, 20mg, and 30mg dosage ...
Yahoo Finance

Mirum’s LIVMARLI Now FDA Approved in Tablet Formulation

FOSTER CITY, Calif., April 14, 2025--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that the U.S. Food and Drug Administration (FDA) has approved a new tablet formulation ...
Yahoo Finance

Viking Therapeutics Announces Initiation of Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

13-Week Study to Evaluate the Safety and Efficacy of Oral VK2735 Dosed Once Daily SAN DIEGO, Jan. 8, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage ...
PharmaTimes

Evgen to investigate new SFX-01 tablet formulation

The therapy has the potential to treat neurological and oncological conditions The therapy has the potential to treat neurological and oncological conditions Evgen – a company developing ...
PharmTech

Formulating the Best Approach for Tablets

An early formulation strategy for tablets that is simple and scalable is recommended to ensure fewer downstream problems. The oral solid dosage formulation market is anticipated to experience growth ...
PMLiVE

Roche’s Evrysdi tablet formulation granted FDA approval for spinal muscular atrophy

Roche has announced that a tablet formulation of its spinal muscular atrophy (SMA) treatment Evrysdi (risdiplam) has been approved by the US Food and Drug Administration (FDA). Evrysdi was originally ...
The American Journal of Managed Care

Risdiplam Tablet for Spinal Muscular Atrophy Receives FDA Approval

The FDA approved a risdiplam tablet for SMA patients aged 2+ and over 44 lbs, matching the oral solution's efficacy and safety. Risdiplam, an SMN2 pre-mRNA splicing modifier, enhances SMN protein ...
PharmiWeb

CD Formulation Provides Pharmaceutical Testing on Tablet Fragility, Dissolution, and Disintegration

Pharmaceutical testing is a must to ensure that all medications meet the top quality, safety, and performance requirements before they enter the market. CD Formulation’s cGMP-compliant laboratory is ...
PharmTech

Evaluating Okra Gum in a Floating Tablet Formulation as a Novel Drug Delivery System

The potential for okra gum as a polymer candidate for new oral drug formulations was evaluated. Okra gum has desirable properties that make it a suitable polymer candidate that can substitute more ...
AFP

European Commission Approves Tablet Formulation of BeOne Medicines’ BRUKINSA® for All Approved Indications

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the European Commission has approved a new film-coated tablet formulation of BRUKINSA ® ...
AFP

U.S. FDA Approves Tablet Formulation of BeOne’s BRUKINSA® for All Approved Indications

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of ...